180 related articles for article (PubMed ID: 16415891)
1. Long-term remission in a patient with hepatosplenic gammadelta T cell lymphoma after cord blood stem cell transplantation following autologous peripheral blood stem cell transplantation.
Sakai R; Fujisawa S; Fujimaki K; Kanamori H; Ishigatsubo Y
Bone Marrow Transplant; 2006 Mar; 37(5):537-8. PubMed ID: 16415891
[No Abstract] [Full Text] [Related]
2. Umbilical cord blood transplantation induces a durable remission in hepatosplenic gamma-delta T cell lymphoma with associated hemophagocytic lymphohistiocytosis.
Ayala E; Chalhoub J; Kharfan-Dabaja MA
Am J Hematol; 2014 Sep; 89(9):934-5. PubMed ID: 24861697
[No Abstract] [Full Text] [Related]
3. Successful allogeneic bone marrow transplantation for hepatosplenic gammadelta T cell lymphoma.
Ooi J; Iseki T; Adachi D; Yamashita T; Tomonari A; Tojo A; Tani K; Asano S
Haematologica; 2001 Oct; 86(10):E25. PubMed ID: 11602432
[No Abstract] [Full Text] [Related]
4. Long-term remission in a patient with hepatosplenic gammadelta T cell lymphoma treated with bortezomib and high-dose CHOP-like chemotherapy followed by autologous peripheral stem cell transplantation.
Otrock ZK; Hatoum HA; Salem ZM; Tawil A; Mahfouz RA; Zaatari GS; Bazarbachi A
Ann Hematol; 2008 Dec; 87(12):1023-4. PubMed ID: 18587577
[No Abstract] [Full Text] [Related]
5. High-dose chemotherapy and autologous stem cell transplantation for peripheral T-cell lymphoma: complete response at transplant predicts survival.
Kim MK; Kim S; Lee SS; Sym SJ; Lee DH; Jang S; Park CJ; Chi HS; Huh J; Suh C
Ann Hematol; 2007 Jun; 86(6):435-42. PubMed ID: 17256144
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of advanced peripheral T-cell lymphoma with an angiocentric growth pattern complicated with hemophagocytic syndrome by high-dose chemotherapy and autologous peripheral blood stem cell transplantation.
Sato T; Kogawa K; Iyama S; Kobayashi D; Sato Y; Kuribayashi K; Takada K; Hagiwara S; Oku T; Takahashi S; Matsunaga T; Takahashi M; Terui T; Kato J; Niitsu Y
Ann Hematol; 2002 Dec; 81(12):739-43. PubMed ID: 12483373
[TBL] [Abstract][Full Text] [Related]
7. T-cell gamma/delta hepatosplenic lymphoma - prolonged remission induced by aggressive first line treatment.
Procházka V; Papajík T; Jarosová M; Pikalová Z; Indrák K; Tichý M; Kucerová L; Fakan F; Bílý M; Starostka D
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Dec; 149(2):275-6. PubMed ID: 16601770
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic stem cell transplantation for hepatosplenic gammadelta T-cell lymphoma.
Konuma T; Ooi J; Takahashi S; Tomonari A; Tsukada N; Kobayashi T; Sato A; Tojo A; Asano S
Leuk Lymphoma; 2007 Mar; 48(3):630-2. PubMed ID: 17454612
[No Abstract] [Full Text] [Related]
9. Successful autologous peripheral blood stem cell transplantation with rituximab administration for pediatric diffuse large B-cell lymphoma.
Imamura T; Yoshihara T; Morimoto A; Ishida H; Sugimoto T; Imashuku S
Pediatr Hematol Oncol; 2006; 23(1):19-24. PubMed ID: 16326408
[TBL] [Abstract][Full Text] [Related]
10. Sustained complete remission of refractory enteropathy-type T-cell lymphoma following reduced-intensity unrelated cord blood transplantation.
Chonabayashi K; Kondo T; Tanaka Y; Ichinohe T; Ishikawa T; Uchiyama T
Bone Marrow Transplant; 2007 Nov; 40(9):905-6. PubMed ID: 17704787
[No Abstract] [Full Text] [Related]
11. Relapse of primitive mediastinal lymphoma as a myeloid mass following beam autologous transplant and subsequent refractoriness to matched unrelated umbilical cord blood allograft.
Anoop P; Lancaster DL; Ethell ME; Potter MN; Wotherspoon A
Pediatr Hematol Oncol; 2009 Mar; 26(2):93-9. PubMed ID: 19322740
[TBL] [Abstract][Full Text] [Related]
12. Long-term remission of blastic natural killer-cell lymphoma after autologous peripheral blood stem-cell transplantation.
Yamaguchi M; Maekawa M; Nakamura Y; Ueda M
Am J Hematol; 2005 Oct; 80(2):124-7. PubMed ID: 16184583
[TBL] [Abstract][Full Text] [Related]
13. Hepatosplenic gammadelta T-cell lymphoma after liver transplantation: report of the first 2 cases and review of the literature.
Roelandt PR; Maertens J; Vandenberghe P; Verslype C; Roskams T; Aerts R; Nevens F; Dierickx D
Liver Transpl; 2009 Jul; 15(7):686-92. PubMed ID: 19562701
[TBL] [Abstract][Full Text] [Related]
14. Hepatosplenic gammadelta T-cell lymphoma in a 10-year-old boy successfully treated with hematopoietic stem cell transplantation.
Gassas A; Kirby M; Weitzman S; Ngan B; Abla O; Doyle JJ
Am J Hematol; 2004 Feb; 75(2):113-4. PubMed ID: 14755380
[TBL] [Abstract][Full Text] [Related]
15. Challenges and new prospects in hepatosplenic γδ T-cell lymphoma.
Calvaruso M; Gulino A; Buffa S; Guarnotta C; Franco G; Cacciatore M; Bonura MG; Franco V; Florena AM
Leuk Lymphoma; 2014 Nov; 55(11):2457-65. PubMed ID: 24506469
[TBL] [Abstract][Full Text] [Related]
16. Managing hepatosplenic gammadelta T-cell leukemia-lymphoma in children.
Lo Nigro L; Munda S; Poli A; Licciardello M; D'Amico S; Di Cataldo A
Pediatr Blood Cancer; 2007 Oct; 49(5):763. PubMed ID: 17120239
[No Abstract] [Full Text] [Related]
17. Retinal hemorrhages as a presenting sign in an adolescent patient with hepatosplenic gamma-delta T-cell lymphoma.
Edwards J; Simmons E; Cordero S; Lieuw K; Roberts S
Pediatr Blood Cancer; 2010 Jul; 55(1):190-2. PubMed ID: 20486185
[TBL] [Abstract][Full Text] [Related]
18. Prolonged survival of patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation: the GELTAMO experience.
Rodríguez J; Conde E; Gutiérrez A; Arranz R; Gandarillas M; Leon A; Ojanguren J; Sureda A; Carrera D; Bendandi M; Moraleda J; Ribera JM; Albo C; Morales A; García JC; Fernández P; Cañigral G; Bergua J; Caballero MD;
Eur J Haematol; 2007 Apr; 78(4):290-6. PubMed ID: 17378891
[TBL] [Abstract][Full Text] [Related]
19. Long-term remission after autologous peripheral blood stem cell transplantation for relapsed intravascular lymphoma.
Sawamoto A; Narimatsu H; Suzuki T; Kurahashi S; Sugimoto T; Sugiura I
Bone Marrow Transplant; 2006 Jan; 37(2):233-4. PubMed ID: 16284609
[No Abstract] [Full Text] [Related]
20. The first 2 years of clinical experience with peripheral blood stem cell transplantation for various hematological malignancies: results from a single Baskent University Center.
Ozdogu H; Boga C; Kizilkilic E; Kozanoglu I; Karakus S; Sahin FI; Unalan D; Haberal M
Transplant Proc; 2007 May; 39(4):1257-60. PubMed ID: 17524948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
